Michael F. Roman

Michael F. Roman, listed as chief executive, has filed trades across 3 companies (mainly through SEC (Form 4)), most often in 3M Co, Abbott Laboratories and Waystar Holding Corp. We count 23 filings; the first trade dates from 2 February 2016 and the latest from 3 June 2026.

No open-market purchase appears, only 1 sale worth €468k. Outside the open market, there are 18 share grants and 4 option exercises.

The newest entry dates from 25 September 2026: a share grant, in Waystar Holding Corp. Typically, a trade is published a median of 3 days after it takes place. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.